Structural and functional consequences of the STAT5B^N642H driver mutation.

Area of Science:

• Oncology
• Molecular Biology
• Structural Biology

Background:

• Hyper-activated Signal Transducer and Activator of Transcription 5B (STAT5B) variants are key targets in cancer therapy.
• The STAT5B^N642H mutation is a common driver in aggressive T-cell leukemia/lymphoma, but its molecular basis is not fully understood.

Purpose of the Study:

• To investigate the aggressive nature of STAT5B^N642H in T-cell neoplasia.
• To elucidate the molecular mechanisms underlying STAT5B^N642H-driven T-cell transformation.
• To provide structural and biophysical insights into STAT5B^N642H function for targeted intervention.

Main Methods:

• Hematopoietic expression of STAT5B^N642H in transgenic mice.
• In vivo syngeneic transplant models using STAT5B^N642H-transformed γδ T-cells.
• X-ray crystallography of human STAT5B and STAT5B^N642H.
• Biophysical assays and Molecular Dynamics (MD) simulations.

Main Results:

• STAT5B^N642H expression drives aggressive T-cell neoplasia with multi-organ infiltration in mice.
• STAT5B^N642H specifically transforms γδ T-cells in vivo, mirroring patient data.
• Crystal structures reveal mutation-mediated alterations in SH2 domain conformation.
• Biophysical data indicates STAT5B^N642H can exist in hyper-activated and hyper-inactivated states, resistant to dephosphorylation.
• MD simulations show sustained interchain interactions, stabilizing the mutant dimer.

Conclusions:

• STAT5B^N642H promotes aggressive T-cell leukemia through altered protein conformation and stability.
• The study provides a molecular explanation for STAT5B^N642H's oncogenic potential.
• Findings offer insights for developing targeted therapies against hyper-activated STAT5B in T-cell malignancies.